pharmaphorum

NOVEMBER 14, 2022

GSK has had another setback in its oncology business, after the FDA asked it to restrict use of its PARP inhibitor Zejula in ovarian, fallopian tube, or primary peritoneal cancer to patients with a specific mutation. That was due last Friday, but cancelled when GSK opted to withdraw the approval.

Labelling 52

Labelling Chemotherapy FDA Vaccines 52

pharmaphorum

JULY 19, 2021

Recent successes in FDA approvals of antibody–drug conjugates (ADCs), RNA therapeutics and the UK’s regulatory leadership in coronavirus vaccines show that complex medicines are having a global impact. But the benefits of complex medicines go far beyond those we have seen with these vaccines.

Vaccines 52

Vaccines Chemotherapy FDA 52

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. The FDA has gone on to grant a fast review of the results ahead of a regulatory decision on the new lung cancer indication next year. months, compared with 6.7

FDA 80

FDA Chemotherapy Compounding Vaccines 80

Hospital Pharmacy Europe

FEBRUARY 15, 2024

They are] administered by the same nurses who would normally give chemotherapy’, Dr Tucker says. However, she adds that ‘approaches using, for example, T-cell stimulating vaccines are currently being explored’. Undoubtedly, much more research, development and clinical applications of bispecific antibodies can be expected.

Chemotherapy 52

Chemotherapy Hospitals Immunization Vaccines 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Early-stage cervical cancer patients achieve good recovery through surgery and concurrent chemotherapy, but treatment options are scarce for those with recurrent metastatic cervical cancer. Opdivo is a programmed cell death receptor-1 (PD-1) inhibitor approved by the US Food and Drug Administration (FDA) for the treatment of several cancers.

Vaccines 59

Vaccines Chemotherapy Dosage FDA 59

pharmaphorum

SEPTEMBER 8, 2020

In England for instance, the introduction of a biosimilar to prevent neutropenia in patients undergoing chemotherapy, resulted in a number of Strategic Health Authorities reassessing their guidance relating to this medicine. Unpleasant truth: let’s embrace it and take action.

Chemotherapy 82

Chemotherapy Patient Care Vaccines FDA 82

The Checkup by Singlecare

NOVEMBER 13, 2023

According to the CDC , treatment includes surgery, chemotherapy, radiation therapy, targeted therapy, or a combination of these treatments. To help decrease the risk of shingles, Shingrix vaccine is FDA-approved for adults 50 and older. It is a two-vaccine series and significantly decreases the risk of a shingles outbreak.

Mayo Clinic 52

Mayo Clinic Vaccines Chemotherapy Communication 52

Pharmaceutical Technology

MARCH 2, 2023

Keytruda is indicated in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients whose tumors express PD-L1 and who have received at least one prior chemotherapy regimen. It is also indicated for the treatment of metastatic transitional (urothelial) tract cancer and gastric cancer.

Chemotherapy 40

Chemotherapy FDA Vaccines Immunization 40

Pharmaceutical Technology

JUNE 13, 2023

The US Food and Drug Administration (FDA) approved Ferring Pharmaceuticals’ Prior-Approval Supplement (PAS) to the Biologics License Application (BLA) for the bladder cancer gene-therapy Adstiladrin (nadofaragene firadenovec). Non-muscle invasive bladder cancer is characterised by cancer cells that remain only in the lining of the bladder.

FDA 98

FDA Vaccines Chemotherapy Communication 98